Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.
Chung GE, Heo NJ, Park MJ, Chung SJ, Kang HY, Kang SJ.
World J Gastroenterol. 2013 Jan 7;19(1):97-102. doi: 10.3748/wjg.v19.i1.97.
Related citations
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.
Kwak MS, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS.
Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21.
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE.
Am J Gastroenterol. 2012 Dec;107(12):1852-8. doi: 10.1038/ajg.2012.314. Epub 2012 Oct 2.
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.
Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, Yoon JH, Lee HS.
J Hepatol. 2012 Jul;57(1):150-6. doi: 10.1016/j.jhep.2012.02.027. Epub 2012 Mar 14.
Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea.
Chung SJ, Park MJ, Kang SJ, Kang HY, Chung GE, Kim SG, Jung HC.
Int J Cancer. 2012 Nov 15;131(10):2376-84. doi: 10.1002/ijc.27501. Epub 2012 Apr 16.
Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain.
Yang JI, Kang JM, Byun HJ, Chung GE, Yim JY, Park MJ, Lee JH, Yoon JH, Lee HS.
Korean J Hepatol. 2011 Dec;17(4):319-22. doi: 10.3350/kjhep.2011.17.4.319.
Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE, Lee JH, Yoon JH, Myung SJ, Lee K, Jang JJ, Lee JM, Kim SH, Suh KS, Kim YJ, Lee HS.
Abdom Imaging. 2012 Jun;37(3):439-46. doi: 10.1007/s00261-011-9756-3.
Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Kwak MS, Lee JH, Chung GE, Yu SJ, Jung EU, Kim BH, Choi DH, Kim HY, Kim SH, Lee JM, Lee JY, Kim YJ, Yoon JH, Lee HS.
Hepatogastroenterology. 2011 Jan-Feb;58(105):147-52.
Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults.
Chung GE, Yim JY, Kim D, Lim SH, Park MJ, Kim YS, Yang SY, Yang JI, Cho SH.
Gut Liver. 2011 Mar;5(1):88-92. doi: 10.5009/gnl.2011.5.1.88. Epub 2011 Mar 16.
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Chung GE, Yoon JH, Lee JH, Kim HY, Myung SJ, Yu SJ, Lee SH, Lee SM, Kim YJ, Lee HS.
Oncol Rep. 2011 Jun;25(6):1739-46. doi: 10.3892/or.2011.1239. Epub 2011 Mar 29.
Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.
Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS.
Korean J Hepatol. 2010 Dec;16(4):389-96. doi: 10.3350/kjhep.2010.16.4.389.
Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease.
Kim HL, Chung GE, Park IY, Choi JM, Hwang SM, Lee JH, Kim D.
Tohoku J Exp Med. 2011;223(3):227-33.
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
Chung GE, Lee JH, Kim HY, Hwang SY, Kim JS, Chung JW, Yoon JH, Lee HS, Kim YJ.
Radiology. 2011 Feb;258(2):627-34. doi: 10.1148/radiol.10101058.
Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.
Yu SJ, Kim DH, Lee JH, Chung GE, Yim JY, Park MJ, Kim YJ, Yoon JH, Jang JJ, Lee HS.
Korean J Gastroenterol. 2011 Jan;57(1):19-27.
Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.
Chung GE, Kim W, Lee KL, Hwang SY, Lee JH, Kim HY, Jung YJ, Kim D, Jeong JB, Kim BG, Kim YJ, Yoon JH, Lee HS.
Dig Dis Sci. 2011 Jul;56(7):2130-6. doi: 10.1007/s10620-010-1561-2. Epub 2011 Jan 21. Erratum in: Dig Dis Sci. 2011 Aug;56(8):2509.
Mesalamine-induced B7-H1 expression on hepatic stellate cells attenuates autoimmune liver injury.
Lee JH, Yoon JH, Lee YJ, Yang JI, Kwak MS, Cho EJ, Jang ES, Yu SJ, Choi DH, Jung EU, Kim HY, Kim BH, Chung GE, Kim YJ, Jang JJ, Kim CY, Lee HS.
Hepatol Res. 2011 Jan;41(1):79-86. doi: 10.1111/j.1872-034X.2010.00735.x. Epub 2010 Oct 25.
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
Lee JH, Yoon JH, Yu SJ, Chung GE, Jung EU, Kim HY, Kim BH, Choi DH, Myung SJ, Kim YJ, Kim CY, Lee HS.
Cancer Lett. 2010 Sep 28;295(2):229-35. doi: 10.1016/j.canlet.2010.03.005. Epub 2010 Mar 28.
Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, Yoon JH, Lee HS, Yi NJ, Suh KS, Lee KU, Jang JJ, Kim YJ.
J Clin Gastroenterol. 2011 Jan;45(1):69-75. doi: 10.1097/MCG.0b013e3181ce5dfa.
High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Kim SJ, Hwang SY, Lee HS, Kim CY.
Oncol Rep. 2010 Jan;23(1):113-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on